Details for New Drug Application (NDA): 018582
✉ Email this page to a colleague
NDA 018582 describes PROCALAMINE, which is a drug marketed by B Braun and is included in one NDA. Additional details are available on the PROCALAMINE profile page.
The generic ingredient in PROCALAMINE is amino acids; calcium acetate; glycerin; magnesium acetate; phosphoric acid; potassium chloride; sodium acetate; sodium chloride. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; calcium acetate; glycerin; magnesium acetate; phosphoric acid; potassium chloride; sodium acetate; sodium chloride profile page.
The generic ingredient in PROCALAMINE is amino acids; calcium acetate; glycerin; magnesium acetate; phosphoric acid; potassium chloride; sodium acetate; sodium chloride. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; calcium acetate; glycerin; magnesium acetate; phosphoric acid; potassium chloride; sodium acetate; sodium chloride profile page.
Summary for 018582
| Tradename: | PROCALAMINE |
| Applicant: | B Braun |
| Ingredient: | amino acids; calcium acetate; glycerin; magnesium acetate; phosphoric acid; potassium chloride; sodium acetate; sodium chloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 3%;26MG/100ML;3GM/100ML;54MG/100ML;41MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML | ||||
| Approval Date: | May 8, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
